Expert Review Of Pharmacoeconomics & Outcomes Research

Journal Title：Expert Review Of Pharmacoeconomics & Outcomes Research

Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review.

The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points.

《药物经济学与结果研究专家评论》（ISSN 1473-7167）提供与药物临床使用和治疗方法相关的成本效益和药物经济学问题的专家评论。内容包括药物经济学和生活质量研究、治疗结果、循证医学和成本效益研究。所有文章均经过严格的同行评审。

该期刊采用独特的专家评论文章格式，全面概述关键技术领域、研究或临床实践的当前思想，并辅以以下部分：

专家意见 - 对文章中呈现的数据的个人看法、对未来可能重要的发展的讨论以及随着进一步研究产生更详细的结果而可能变得令人兴奋的研究途径

文章重点 - 作者最关键观点的执行摘要。

Expert Review Of Pharmacoeconomics & Outcomes Research创刊于2001年，由Taylor and Francis Ltd.出版商出版，收稿方向涵盖HEALTH CARE SCIENCES & SERVICES - PHARMACOLOGY & PHARMACY全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 较慢,6-12周 ，影响因子指数1.8，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。